# Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity

> **NCT05017571** · PHASE2 · COMPLETED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 152 (actual)

## Conditions studied

- Obesity
- Insulin Resistance
- Inflammation

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05017571
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-08
- **Primary completion:** 2025-09-02
- **Final completion:** 2025-09-02
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2025-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05017571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05017571, "Colchicine to Suppress Inflammation and Improve Insulin Resistance in Adults and Adolescents With Obesity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05017571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*